The FDA has reportedly refused to review Moderna's application for an mRNA flu vaccine, although there is some uncertainty about the decision. Some outlets suggest the FDA reversed its course in making this decision, while others simply state that the review was refused. The status of the application is unclear, with one outlet contradicting the others by stating that the FDA will review the vaccine.